http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2695568-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50def7e23a113a43599325d77086d629 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a4d6db20d6ee53a839d54df9185985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e916b390ddf72d8c8059d8f599be8cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f63b7e2a1447f4e74c6bd5a8e02c9f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a29e938e758216c3d47dfd8fe395be77 |
| publicationDate | 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2695568-C1 |
| titleOfInvention | Method for screening antitumour preparations in vitro on a multicomponent cell test system |
| abstract | FIELD: biotechnology. n SUBSTANCE: invention refers to biotechnology, namely to screening antitumour preparations in vitro on a multicomponent cell test system. Method involves co-cultivation of tumor, stromal and immune cells on any of the known extracellular matrix analogues to produce a multicomponent cell co-culture (test system). Then the analyzed substance is added to the obtained multicomponent cell co-culture, incubation is performed, antitumor activity of the test substance is determined by analyzing the viability of the multicomponent cell co-culture using known methods of cell biology with obtaining results on the presence or absence of anticancer activity of the test substance with subsequent extraction of promising substances with high anticancer activity for further stages of preclinical screening or refusal of further screening of the analyzed substance in case the analyzed substance has no evident antitumour activity. n EFFECT: invention provides higher effectiveness of primary screening of substances with potential anti-tumor activity. n 1 cl, 4 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2798541-C1 |
| priorityDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.